438 related articles for article (PubMed ID: 26895288)
21. Small molecule modulators in epigenetics: implications in gene expression and therapeutics.
Swaminathan V; Reddy BA; Ruthrotha Selvi B; Sukanya MS; Kundu TK
Subcell Biochem; 2007; 41():397-428. PubMed ID: 17484138
[TBL] [Abstract][Full Text] [Related]
22. An in vitro investigation of metabolically sensitive biomarkers in breast cancer progression.
Simpson NE; Tryndyak VP; Beland FA; Pogribny IP
Breast Cancer Res Treat; 2012 Jun; 133(3):959-68. PubMed ID: 22101407
[TBL] [Abstract][Full Text] [Related]
23. [Development of novel epigenetic molecular-targeting agents].
Sowa Y; Sakai T
Nihon Rinsho; 2015 Aug; 73(8):1263-7. PubMed ID: 26281676
[TBL] [Abstract][Full Text] [Related]
24. Deacetylation of Transcription Factors in Carcinogenesis.
Halasa M; Adamczuk K; Adamczuk G; Afshan S; Stepulak A; Cybulski M; Wawruszak A
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769241
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic Targets and their Inhibitors in Cancer Therapy.
Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS
Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481
[TBL] [Abstract][Full Text] [Related]
26. Histone Deacetylase Inhibitors in Cancer Therapy.
Sun Y; Sun Y; Yue S; Wang Y; Lu F
Curr Top Med Chem; 2018; 18(28):2420-2428. PubMed ID: 30526462
[TBL] [Abstract][Full Text] [Related]
27. HDACi--going through the mechanisms.
Wanczyk M; Roszczenko K; Marcinkiewicz K; Bojarczuk K; Kowara M; Winiarska M
Front Biosci (Landmark Ed); 2011 Jan; 16(1):340-59. PubMed ID: 21196174
[TBL] [Abstract][Full Text] [Related]
28. Quercetin modifies 5'CpG promoter methylation and reactivates various tumor suppressor genes by modulating epigenetic marks in human cervical cancer cells.
Kedhari Sundaram M; Hussain A; Haque S; Raina R; Afroze N
J Cell Biochem; 2019 Oct; 120(10):18357-18369. PubMed ID: 31172592
[TBL] [Abstract][Full Text] [Related]
29. Histone modifications: A review about the presence of this epigenetic phenomenon in carcinogenesis.
Chrun ES; Modolo F; Daniel FI
Pathol Res Pract; 2017 Nov; 213(11):1329-1339. PubMed ID: 28882400
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
31. Reversing aberrant methylation patterns in cancer.
Poke FS; Qadi A; Holloway AF
Curr Med Chem; 2010; 17(13):1246-54. PubMed ID: 20166939
[TBL] [Abstract][Full Text] [Related]
32. Small molecule inhibitors of histone acetyltransferases as epigenetic tools and drug candidates.
Furdas SD; Kannan S; Sippl W; Jung M
Arch Pharm (Weinheim); 2012 Jan; 345(1):7-21. PubMed ID: 22234972
[TBL] [Abstract][Full Text] [Related]
33. Epigenetics in ovarian cancer: premise, properties, and perspectives.
Yang Q; Yang Y; Zhou N; Tang K; Lau WB; Lau B; Wang W; Xu L; Yang Z; Huang S; Wang X; Yi T; Zhao X; Wei Y; Wang H; Zhao L; Zhou S
Mol Cancer; 2018 Jul; 17(1):109. PubMed ID: 30064416
[TBL] [Abstract][Full Text] [Related]
34. Curcumin as a regulator of epigenetic events.
Teiten MH; Dicato M; Diederich M
Mol Nutr Food Res; 2013 Sep; 57(9):1619-29. PubMed ID: 23754571
[TBL] [Abstract][Full Text] [Related]
35. Promises and challenges of anticancer drugs that target the epigenome.
Verbrugge I; Johnstone RW; Bots M
Epigenomics; 2011 Oct; 3(5):547-65. PubMed ID: 22126246
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic Implications of Epigenetic Signaling in Breast Cancer.
Oh TG; Wang SM; Muscat GE
Endocrinology; 2017 Mar; 158(3):431-447. PubMed ID: 27983866
[TBL] [Abstract][Full Text] [Related]
37. KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases.
Simon RP; Robaa D; Alhalabi Z; Sippl W; Jung M
J Med Chem; 2016 Feb; 59(4):1249-70. PubMed ID: 26701186
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic targeting in breast cancer: therapeutic impact and future direction.
Lustberg MB; Ramaswamy B
Drug News Perspect; 2009 Sep; 22(7):369-81. PubMed ID: 19890494
[TBL] [Abstract][Full Text] [Related]
39. Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer.
Mohammad HP; Barbash O; Creasy CL
Nat Med; 2019 Mar; 25(3):403-418. PubMed ID: 30842676
[TBL] [Abstract][Full Text] [Related]
40. Epigenetics of Breast Cancer: Clinical Status of Epi-drugs and Phytochemicals.
Shukla S; Penta D; Mondal P; Meeran SM
Adv Exp Med Biol; 2019; 1152():293-310. PubMed ID: 31456191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
